{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:13:08Z","timestamp":1772165588386,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T00:00:00Z","timestamp":1702512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mitral valve stenosis can be a highly symptomatic condition with significant complications if left untreated. In such cases, mitral valve replacement with a bioprosthetic or mechanical valve may be a viable solution to prevent progressive disease. Current guidelines do not recommend continued anticoagulation beyond 6 months for patients who have undergone bioprosthetic valve replacement without a separate indication for anticoagulation. With this case discussion we aim to 1) Review the current indications for anticoagulation for bioprosthetic mitral valves in patients without atrial fibrillation and 2) Discuss the constellation of comorbidities that may affect the decision to begin anticoagulation therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We present a case describing a 55-year-old male with end-stage renal disease, coronary artery disease with coronary artery bypass graft surgery, and bioprosthetic mitral valve replacement 2 years prior with rapid degeneration of the replaced valve and on warfarin without a clear indication for anticoagulation. The patient was admitted for symptomatic, severe mitral stenosis and consideration of transcatheter mitral valve-in-valve replacement. During hospital admission, warfarin was discontinued and replaced with prophylactic anticoagulation. However, 8 days after warfarin cessation an intraoperative transesophageal echocardiography revealed a newly developed large left atrial thrombus leading to cancellation of the planned operation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This patient developed a left atrial thrombus after discontinuing warfarin in the setting of rapidly deteriorating bioprosthetic valve stenosis and vascular comorbidities. The decision to discontinue warfarin was made in concordance with current guidelines, which do not indicate systemic anticoagulation post 3\u20136\u2009months after bioprosthetic valve replacement without separate indication for anticoagulation. This case identifies the need to investigate rebound hypercoagulability and further risk stratify comorbidities which may independently increase the risk of clot formation in the setting of severe mitral valve stenosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-023-03644-7","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T01:09:41Z","timestamp":1702516181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Left atrial Thrombus formation after discontinuation of anticoagulation in patient with severe bioprosthetic mitral stenosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Ryan C.","family":"King","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobin","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stella","family":"Whang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ned","family":"Premyodhin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranav","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,14]]},"reference":[{"issue":"5","key":"3644_CR1","first-page":"e72","volume":"143","author":"CM Otto","year":"2021","unstructured":"Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC\/AHA guideline for the Management of Patients with Valvular Heart Disease: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines. Circulation. 2021;143(5):e72\u2013e227.","journal-title":"Circulation."},{"key":"3644_CR2","doi-asserted-by":"publisher","first-page":"e02","DOI":"10.15420\/ecr.2021.25","volume":"17","author":"K Kipourou","year":"2022","unstructured":"Kipourou K, O'Driscoll JM, Sharma R. Valvular heart disease in patients with chronic kidney disease. Eur Cardiol. 2022;17:e02.","journal-title":"Eur Cardiol."},{"key":"3644_CR3","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/B0-08-043152-6\/00247-3","volume-title":"Encyclopedia of materials: science and technology","author":"PB van Wachem","year":"2001","unstructured":"van Wachem PB, van Luyn MJA. Collagen Derived Materials. In: Buschow KHJ, Cahn RW, Flemings MC, Ilschner B, Kramer EJ, Mahajan S, et al., editors. Encyclopedia of materials: science and technology. Oxford: Elsevier; 2001. p. 1313\u20134."},{"issue":"4","key":"3644_CR4","first-page":"399","volume":"4","author":"C Harris","year":"2015","unstructured":"Harris C, Croce B, Cao C. Tissue and mechanical heart valves. Ann Cardiothorac Surg. 2015;4(4):399.","journal-title":"Ann Cardiothorac Surg."},{"issue":"8","key":"3644_CR5","first-page":"143","volume":"105","author":"G Hoffmann","year":"2008","unstructured":"Hoffmann G, Lutter G, Cremer J. Durability of bioprosthetic cardiac valves. Dtsch Arztebl Int. 2008;105(8):143\u20138.","journal-title":"Dtsch Arztebl Int."},{"issue":"2","key":"3644_CR6","doi-asserted-by":"publisher","first-page":"e011148","DOI":"10.1161\/CIRCIMAGING.120.011148","volume":"14","author":"T Mishra","year":"2021","unstructured":"Mishra T, Dawdy J, Sood A, Kottam A, Afonso L. Late-onset bioprosthetic mitral valve thrombosis treated with Apixaban. Circ Cardiovasc Imag. 2021;14(2):e011148.","journal-title":"Circ Cardiovasc Imag."},{"issue":"2","key":"3644_CR7","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1053\/cd.2000.v25.a103682","volume":"25","author":"GL Grunkemeier","year":"2000","unstructured":"Grunkemeier GL, Li HH, Naftel DC, Starr A, Rahimtoola SH. Long-term performance of heart valve prostheses. Curr Probl Cardiol. 2000;25(2):73\u2013154.","journal-title":"Curr Probl Cardiol."},{"issue":"21","key":"3644_CR8","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.jacc.2015.09.022","volume":"66","author":"AC Egbe","year":"2015","unstructured":"Egbe AC, Pislaru SV, Pellikka PA, Poterucha JT, Schaff HV, Maleszewski JJ, et al. Bioprosthetic valve thrombosis versus structural failure: clinical and echocardiographic predictors. J Am Coll Cardiol. 2015;66(21):2285\u201394.","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"3644_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.7555\/JBR.31.20170027","volume":"31","author":"PM Applegate","year":"2017","unstructured":"Applegate PM, Boyd WD, Applegate Ii RL, Liu H. Is it the time to reconsider the choice of valves for cardiac surgery: mechanical or bioprosthetic? J Biomed Res. 2017;31(5):373\u20136.","journal-title":"J Biomed Res."},{"issue":"7","key":"3644_CR10","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2021","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;43(7):561\u2013632.","journal-title":"Eur Heart J."},{"issue":"4","key":"3644_CR11","doi-asserted-by":"publisher","first-page":"300","DOI":"10.2165\/00003088-199630040-00003","volume":"30","author":"G Palareti","year":"1996","unstructured":"Palareti G, Legnani C, Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations. Clin Pharmacokinet. 1996;30(4):300\u201313.","journal-title":"Clin Pharmacokinet."},{"issue":"6","key":"3644_CR12","doi-asserted-by":"publisher","first-page":"243","DOI":"10.14740\/jmc3656","volume":"12","author":"M Niazi","year":"2021","unstructured":"Niazi M, Khan D, Mustafa A, Munir AB, Karam B, Snyder ST, et al. Left atrial Thrombus mimicking Myxoma secondary to rebound hypercoagulable state. J Med Cases. 2021;12(6):243\u20137.","journal-title":"J Med Cases."},{"issue":"5","key":"3644_CR13","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/ageing\/afx073","volume":"46","author":"S Nagasayi","year":"2017","unstructured":"Nagasayi S, Varman S, Ting YY, Ang W. Rivaroxaban withdrawal and rebound hypercoagulability leading to upper extremity deep vein thrombosis: a case report. Age Age. 2017;46(5):870\u20131.","journal-title":"Age Age."},{"issue":"3","key":"3644_CR14","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/icvts\/ivab106","volume":"33","author":"Y Kuroda","year":"2021","unstructured":"Kuroda Y, Marui A, Arai Y, Nagasawa A, Tsumaru S, Arakaki R, et al. Impact of dialysis in patients undergoing bioprosthetic aortic valve replacement. Interact Cardiovasc Thorac Surg. 2021;33(3):348\u201353.","journal-title":"Interact Cardiovasc Thorac Surg."},{"issue":"4","key":"3644_CR15","doi-asserted-by":"publisher","first-page":"E450","DOI":"10.1503\/cjs.001121","volume":"65","author":"KS Kim","year":"2022","unstructured":"Kim KS, Belley-C\u00f4t\u00e9 EP, Gupta S, Pandey A, Alsagheir A, Makhdoum A, et al. Mechanical versus bioprosthetic valves in chronic dialysis: a systematic review and meta-analysis. Can J Surg. 2022;65(4):E450\u2013e9.","journal-title":"Can J Surg."},{"issue":"5\u20136","key":"3644_CR16","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1159\/000083845","volume":"33","author":"GD Lowe","year":"2003","unstructured":"Lowe GD. Virchow's triad revisited: abnormal flow. Pathophys Haemost Thromb. 2003;33(5\u20136):455\u20137.","journal-title":"Pathophys Haemost Thromb."},{"issue":"2","key":"3644_CR17","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1530\/ERP-18-0083","volume":"6","author":"T Ito","year":"2019","unstructured":"Ito T, Suwa M. Left atrial spontaneous echo contrast: relationship with clinical and echocardiographic parameters. Echo Res Pract. 2019;6(2):R65\u201373.","journal-title":"Echo Res Pract."},{"issue":"1","key":"3644_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1136\/hrt.2005.071183","volume":"93","author":"R Roudaut","year":"2007","unstructured":"Roudaut R, Serri K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart. 2007;93(1):137\u201342.","journal-title":"Heart."},{"issue":"6","key":"3644_CR19","first-page":"601","volume":"7","author":"M Gencbay","year":"1998","unstructured":"Gencbay M, Turan F, Degertekin M, Eksi N, Mutlu B, Unalp A. High prevalence of hypercoagulable states in patients with recurrent thrombosis of mechanical heart valves. J Heart Valve Dis. 1998;7(6):601\u20139.","journal-title":"J Heart Valve Dis."},{"key":"3644_CR20","doi-asserted-by":"publisher","unstructured":"BRIDGE Study Investigators. Bridging anticoagulation: is it needed when warfarin is interrupted around the time of a surgery or procedure? Circulation. 2012;125(12):e496\u20138. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.","DOI":"10.1161\/CIRCULATIONAHA"},{"issue":"4","key":"3644_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11239-018-1640-3","volume":"45","author":"T \u00c7\u0131nar","year":"2018","unstructured":"\u00c7\u0131nar T, Hay\u0131ro\u011flu MI, Tan\u0131k VO, Aru\u011faslan E, Keskin M, Uluganyan M, et al. The predictive value of the CHA2DS2-VASc score in patients with mechanical mitral valve thrombosis. J Thromb Thrombol. 2018;45(4):571\u20137.","journal-title":"J Thromb Thrombol."}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03644-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-023-03644-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-023-03644-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T01:10:09Z","timestamp":1702516209000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-023-03644-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,14]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3644"],"URL":"https:\/\/doi.org\/10.1186\/s12872-023-03644-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3383326\/v1","asserted-by":"object"}]},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,14]]},"assertion":[{"value":"25 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent for the publication of potentially identifying information and images in an online open-access publication has been obtained from the patient\u2019s spouse.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"616"}}